LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | Radicicol | 0.37 | uM | LJP6 | 72 | hr | 962 | 2892 | 10605 | 0.2727 | 0.2002 |
MCF 10A | Seliciclib | 0.37 | uM | LJP5 | 72 | hr | 962 | 9671 | 10605 | 0.9120 | 0.9032 |
MCF 10A | Ruxolitinib | 0.37 | uM | LJP5 | 72 | hr | 962 | 10167 | 10605 | 0.9588 | 0.9546 |
MCF 10A | XL147 | 0.37 | uM | LJP5 | 72 | hr | 962 | 9449 | 10605 | 0.8911 | 0.8802 |
MCF 10A | Saracatinib | 0.37 | uM | LJP6 | 72 | hr | 962 | 9678 | 10605 | 0.9126 | 0.9039 |
MCF 10A | Selumetinib | 0.37 | uM | LJP6 | 72 | hr | 962 | 3234 | 10605 | 0.3050 | 0.2356 |
MCF 10A | Sirolimus | 0.37 | uM | LJP6 | 72 | hr | 962 | 9293 | 10605 | 0.8763 | 0.8639 |
MCF 10A | Sorafenib | 0.37 | uM | LJP6 | 72 | hr | 962 | 9369 | 10605 | 0.8835 | 0.8719 |
MCF 10A | SU11274 | 0.37 | uM | LJP5 | 72 | hr | 962 | 9108 | 10605 | 0.8589 | 0.8448 |
MCF 10A | Fedratinib | 0.37 | uM | LJP5 | 72 | hr | 962 | 8912 | 10605 | 0.8404 | 0.8245 |
MCF 10A | TGX221 | 0.37 | uM | LJP5 | 72 | hr | 962 | 10319 | 10605 | 0.9731 | 0.9704 |
MCF 10A | Torin1 | 0.37 | uM | LJP6 | 72 | hr | 962 | 1730 | 10605 | 0.1631 | 0.0796 |
MCF 10A | Torin2 | 0.37 | uM | LJP5 | 72 | hr | 962 | 1347 | 10605 | 0.1270 | 0.0399 |
MCF 10A | Tozasertib | 0.37 | uM | LJP5 | 72 | hr | 962 | 1384 | 10605 | 0.1305 | 0.0437 |
MCF 10A | Trametinib | 0.37 | uM | LJP5 | 72 | hr | 962 | 1899 | 10605 | 0.1791 | 0.0972 |
MCF 10A | TWS119 | 0.37 | uM | LJP5 | 72 | hr | 962 | 10718 | 10605 | 1.0107 | 1.0117 |
MCF 10A | Vemurafenib | 0.37 | uM | LJP5 | 72 | hr | 962 | 10309 | 10605 | 0.9721 | 0.9694 |
MCF 10A | Withaferin A | 0.37 | uM | LJP5 | 72 | hr | 962 | 8349 | 10605 | 0.7873 | 0.7661 |
MCF 10A | Withaferin A | 0.37 | uM | LJP6 | 72 | hr | 962 | 8178 | 10605 | 0.7711 | 0.7483 |
MCF 10A | WYE-125132 | 0.37 | uM | LJP6 | 72 | hr | 962 | 1620 | 10605 | 0.1528 | 0.0683 |
MCF 10A | WZ3105 | 0.37 | uM | LJP5 | 72 | hr | 962 | 522 | 10605 | 0.0493 | -0.0456 |
MCF 10A | XMD11-50 | 0.37 | uM | LJP6 | 72 | hr | 962 | 7667 | 10605 | 0.7230 | 0.6953 |
MCF 10A | Y39983 | 0.37 | uM | LJP6 | 72 | hr | 962 | 9470 | 10605 | 0.8930 | 0.8823 |
MCF 10A | YM 201636 | 0.37 | uM | LJP5 | 72 | hr | 962 | 10078 | 10605 | 0.9503 | 0.9453 |
MCF 10A | ZSTK474 | 0.37 | uM | LJP6 | 72 | hr | 962 | 7328 | 10605 | 0.6910 | 0.6602 |